Global Neisseria Gonorrhoeae Infections Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size 2017-2028

2.1.2 Neisseria Gonorrhoeae Infections Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Neisseria Gonorrhoeae Infections Treatment Segment by Type

2.2.1 Cribrostatin-6

2.2.2 Dalbavancin

2.2.3 Debio-1453

2.2.4 Gepotidacin Mesylate

2.2.5 Others

2.3 Neisseria Gonorrhoeae Infections Treatment Market Size by Type

2.3.1 Neisseria Gonorrhoeae Infections Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Type (2017-2022)

2.4 Neisseria Gonorrhoeae Infections Treatment Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Neisseria Gonorrhoeae Infections Treatment Market Size by Application

2.5.1 Neisseria Gonorrhoeae Infections Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application (2017-2022)

3 Neisseria Gonorrhoeae Infections Treatment Market Size by Player

3.1 Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Players

3.1.1 Global Neisseria Gonorrhoeae Infections Treatment Revenue by Players (2020-2022)

3.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Neisseria Gonorrhoeae Infections Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Neisseria Gonorrhoeae Infections Treatment by Regions

4.1 Neisseria Gonorrhoeae Infections Treatment Market Size by Regions (2017-2022)

4.2 Americas Neisseria Gonorrhoeae Infections Treatment Market Size Growth (2017-2022)

4.3 APAC Neisseria Gonorrhoeae Infections Treatment Market Size Growth (2017-2022)

4.4 Europe Neisseria Gonorrhoeae Infections Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2017-2022)

5.2 Americas Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2017-2022)

5.3 Americas Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2017-2022)

6.2 APAC Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2017-2022)

6.3 APAC Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Neisseria Gonorrhoeae Infections Treatment by Country (2017-2022)

7.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2017-2022)

7.3 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment by Region (2017-2022)

8.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.1 Global Neisseria Gonorrhoeae Infections Treatment Forecast by Regions (2023-2028)

10.1.1 Global Neisseria Gonorrhoeae Infections Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Neisseria Gonorrhoeae Infections Treatment Forecast

10.1.3 APAC Neisseria Gonorrhoeae Infections Treatment Forecast

10.1.4 Europe Neisseria Gonorrhoeae Infections Treatment Forecast

10.1.5 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Forecast

10.2 Americas Neisseria Gonorrhoeae Infections Treatment Forecast by Country (2023-2028)

10.2.1 United States Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.2.2 Canada Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.2.3 Mexico Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.2.4 Brazil Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.3 APAC Neisseria Gonorrhoeae Infections Treatment Forecast by Region (2023-2028)

10.3.1 China Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.3.2 Japan Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.3.3 Korea Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.3.4 Southeast Asia Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.3.5 India Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.3.6 Australia Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.4 Europe Neisseria Gonorrhoeae Infections Treatment Forecast by Country (2023-2028)

10.4.1 Germany Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.4.2 France Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.4.3 UK Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.4.4 Italy Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.4.5 Russia Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.5 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.5.2 South Africa Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.5.3 Israel Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.5.4 Turkey Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.5.5 GCC Countries Neisseria Gonorrhoeae Infections Treatment Market Forecast

10.6 Global Neisseria Gonorrhoeae Infections Treatment Forecast by Type (2023-2028)

10.7 Global Neisseria Gonorrhoeae Infections Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Allergan Plc

11.1.1 Allergan Plc Company Information

11.1.2 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product Offered

11.1.3 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Allergan Plc Main Business Overview

11.1.5 Allergan Plc Latest Developments

11.2 BioDiem Ltd

11.2.1 BioDiem Ltd Company Information

11.2.2 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Product Offered

11.2.3 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 BioDiem Ltd Main Business Overview

11.2.5 BioDiem Ltd Latest Developments

11.3 Biolytics Pharma

11.3.1 Biolytics Pharma Company Information

11.3.2 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product Offered

11.3.3 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Biolytics Pharma Main Business Overview

11.3.5 Biolytics Pharma Latest Developments

11.4 Debiopharm International SA

11.4.1 Debiopharm International SA Company Information

11.4.2 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product Offered

11.4.3 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Debiopharm International SA Main Business Overview

11.4.5 Debiopharm International SA Latest Developments

11.5 F. Hoffmann-La Roche Ltd.

11.5.1 F. Hoffmann-La Roche Ltd. Company Information

11.5.2 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Product Offered

11.5.3 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview

11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments

11.6 GlaxoSmithKline Plc

11.6.1 GlaxoSmithKline Plc Company Information

11.6.2 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Product Offered

11.6.3 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 GlaxoSmithKline Plc Main Business Overview

11.6.5 GlaxoSmithKline Plc Latest Developments

11.7 Merck & Co., Inc.

11.7.1 Merck & Co., Inc. Company Information

11.7.2 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Product Offered

11.7.3 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Merck & Co., Inc. Main Business Overview

11.7.5 Merck & Co., Inc. Latest Developments

11.8 Paratek Pharmaceuticals, Inc.

11.8.1 Paratek Pharmaceuticals, Inc. Company Information

11.8.2 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Product Offered

11.8.3 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Paratek Pharmaceuticals, Inc. Main Business Overview

11.8.5 Paratek Pharmaceuticals, Inc. Latest Developments

11.9 Recce Pty Ltd

11.9.1 Recce Pty Ltd Company Information

11.9.2 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Product Offered

11.9.3 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Recce Pty Ltd Main Business Overview

11.9.5 Recce Pty Ltd Latest Developments

11.10 Redx Pharma Plc

11.10.1 Redx Pharma Plc Company Information

11.10.2 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Product Offered

11.10.3 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Redx Pharma Plc Main Business Overview

11.10.5 Redx Pharma Plc Latest Developments

11.11 Sarepta Therapeutics, Inc.

11.11.1 Sarepta Therapeutics, Inc. Company Information

11.11.2 Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Product Offered

11.11.3 Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Sarepta Therapeutics, Inc. Main Business Overview

11.11.5 Sarepta Therapeutics, Inc. Latest Developments

11.12 Sumitomo Dainippon Pharma Co., Ltd.

11.12.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information

11.12.2 Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Product Offered

11.12.3 Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Sumitomo Dainippon Pharma Co., Ltd. Main Business Overview

11.12.5 Sumitomo Dainippon Pharma Co., Ltd. Latest Developments

12 Research Findings and Conclusion

Table 1. Neisseria Gonorrhoeae Infections Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Cribrostatin-6

Table 3. Major Players of Dalbavancin

Table 4. Major Players of Debio-1453

Table 5. Major Players of Gepotidacin Mesylate

Table 6. Major Players of Others

Table 7. Neisseria Gonorrhoeae Infections Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Type (2017-2022)

Table 10. Neisseria Gonorrhoeae Infections Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application (2017-2022)

Table 13. Global Neisseria Gonorrhoeae Infections Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Player (2020-2022)

Table 15. Neisseria Gonorrhoeae Infections Treatment Key Players Head office and Products Offered

Table 16. Neisseria Gonorrhoeae Infections Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Regions (2017-2022)

Table 21. Americas Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Country (2017-2022)

Table 23. Americas Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Type (2017-2022)

Table 25. Americas Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application (2017-2022)

Table 27. APAC Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Region (2017-2022)

Table 29. APAC Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Type (2017-2022)

Table 31. APAC Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application (2017-2022)

Table 33. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Country (2017-2022)

Table 35. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Type (2017-2022)

Table 37. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Neisseria Gonorrhoeae Infections Treatment

Table 46. Key Market Challenges & Risks of Neisseria Gonorrhoeae Infections Treatment

Table 47. Key Industry Trends of Neisseria Gonorrhoeae Infections Treatment

Table 48. Global Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 54. Allergan Plc Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 55. Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 56. Allergan Plc Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Allergan Plc Main Business

Table 58. Allergan Plc Latest Developments

Table 59. BioDiem Ltd Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 60. BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 61. BioDiem Ltd Main Business

Table 62. BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. BioDiem Ltd Latest Developments

Table 64. Biolytics Pharma Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 65. Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 66. Biolytics Pharma Main Business

Table 67. Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Biolytics Pharma Latest Developments

Table 69. Debiopharm International SA Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 70. Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 71. Debiopharm International SA Main Business

Table 72. Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Debiopharm International SA Latest Developments

Table 74. F. Hoffmann-La Roche Ltd. Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 75. F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 76. F. Hoffmann-La Roche Ltd. Main Business

Table 77. F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. F. Hoffmann-La Roche Ltd. Latest Developments

Table 79. GlaxoSmithKline Plc Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 80. GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 81. GlaxoSmithKline Plc Main Business

Table 82. GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. GlaxoSmithKline Plc Latest Developments

Table 84. Merck & Co., Inc. Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 85. Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 86. Merck & Co., Inc. Main Business

Table 87. Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Merck & Co., Inc. Latest Developments

Table 89. Paratek Pharmaceuticals, Inc. Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 90. Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 91. Paratek Pharmaceuticals, Inc. Main Business

Table 92. Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Paratek Pharmaceuticals, Inc. Latest Developments

Table 94. Recce Pty Ltd Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 95. Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 96. Recce Pty Ltd Main Business

Table 97. Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Recce Pty Ltd Latest Developments

Table 99. Redx Pharma Plc Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 100. Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 101. Redx Pharma Plc Main Business

Table 102. Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Redx Pharma Plc Latest Developments

Table 104. Sarepta Therapeutics, Inc. Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 105. Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 106. Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. Sarepta Therapeutics, Inc. Main Business

Table 108. Sarepta Therapeutics, Inc. Latest Developments

Table 109. Sumitomo Dainippon Pharma Co., Ltd. Details, Company Type, Neisseria Gonorrhoeae Infections Treatment Area Served and Its Competitors

Table 110. Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Product Offered

Table 111. Sumitomo Dainippon Pharma Co., Ltd. Main Business

Table 112. Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. Sumitomo Dainippon Pharma Co., Ltd. Latest Developments

List of Figures

Figure 1. Neisseria Gonorrhoeae Infections Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Type in 2021

Figure 7. Neisseria Gonorrhoeae Infections Treatment in Clinic

Figure 8. Global Neisseria Gonorrhoeae Infections Treatment Market: Clinic (2017-2022) & ($ Millions)

Figure 9. Neisseria Gonorrhoeae Infections Treatment in Hospital

Figure 10. Global Neisseria Gonorrhoeae Infections Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 11. Neisseria Gonorrhoeae Infections Treatment in Others

Figure 12. Global Neisseria Gonorrhoeae Infections Treatment Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application in 2021

Figure 14. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Player in 2021

Figure 15. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Neisseria Gonorrhoeae Infections Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Neisseria Gonorrhoeae Infections Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Neisseria Gonorrhoeae Infections Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Neisseria Gonorrhoeae Infections Treatment Value Market Share by Country in 2021

Figure 21. Americas Neisseria Gonorrhoeae Infections Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application in 2021

Figure 23. United States Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application in 2021

Figure 29. China Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Neisseria Gonorrhoeae Infections Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Neisseria Gonorrhoeae Infections Treatment Market Size 2023-2028 ($ Millions)